An update from Japan Tobacco ( (JP:2914) ) is now available.
Japan Tobacco Inc. announced revisions to its 2024 full-year results and 2025 forecasts due to a retroactive provision for litigation losses of 375.6 billion yen related to its Canadian subsidiary. This adjustment impacts the company’s financial reporting and highlights the ongoing legal challenges faced by the company, potentially affecting its financial stability and stakeholder confidence.
More about Japan Tobacco
Japan Tobacco Inc. (JT) is a global company headquartered in Tokyo, Japan, listed on the Tokyo Stock Exchange. It operates in three business segments: tobacco, pharmaceutical, and processed food, with the tobacco segment being the largest. The company markets its products in over 130 countries, with flagship brands including Winston, Camel, MEVIUS, and LD. JT is also investing in Reduced-Risk Products, such as its Ploom brand of heated tobacco products.
YTD Price Performance: -0.29%
Average Trading Volume: 523
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $46.31B
For detailed information about 2914 stock, go to TipRanks’ Stock Analysis page.